Endothelial Dysfunction Market
完整報告名稱與涵蓋範圍
Endothelial Dysfunction Market Size, Share & Trends Analysis Report By Cause (Hypertension, Diabetes, Hypercholesterolemia, Baches’s disease, Obesity, Others), By Test Type (Invasive, Non-invasive tests), By End-User, By Region, And By Segment Forecasts, 2023-2031
報告摘要
With a 2022 valuation of USD 1.84 Bn, the global Endothelial Dysfunction Market is projected to accelerate to USD 2.63 Bn by 2031, demonstrating a CAGR of 4.1% during the 2023–2031 forecast window.
The Endothelial Dysfunction sector involves a condition characterised by impaired or compromised functioning of the inner lining of blood vessels, the endothelium. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Endothelial Dysfunction Market Snapshot
Chapter 4. Global Endothelial Dysfunction Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Cause Estimates & Trend Analysis
5.1. By Cause, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Cause:
5.2.1. Hypertension
5.2.2. Diabetes
5.2.3. Hypercholestrolaemia
5.2.4. Bechet's Disease
5.2.5. Obesity
5.2.6. Others
Chapter 6. Market Segmentation 2: By Test Type Estimates & Trend Analysis
6.1. By Test Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Test Type:
6.2.1. Invasive Tests
6.2.2. Non-Invasive Tests
6.2.2.1. Flow Mediated Dilatory
6.2.2.2. Peripheral Arterial Tonometry (PAT)
6.2.2.3. Venous Occlusion Pletismography
6.2.2.4. Circulating Markers
6.2.2.5. Others
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
7.2.1. Hospitals
7.2.2. Ambulatory Surgery Centers
7.2.3. Specialty Clinics
7.2.4. Others
Chapter 8. Endothelial Dysfunction Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts By Cause, 2019-2031
8.1.2. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts By Test Type, 2019-2031
8.1.3. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
8.1.4. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Endothelial Dysfunction Market revenue (US$ Million) By Cause, 2019-2031
8.2.2. Europe Endothelial Dysfunction Market revenue (US$ Million) By Test Type, 2019-2031
8.2.3. Europe Endothelial Dysfunction Market revenue (US$ Million) By End User, 2019-2031
8.2.4. Europe Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) By Cause, 2019-2031
8.3.2. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) By Test Type, 2019-2031
8.3.3. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) By End User, 2019-2031
8.3.4. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Endothelial Dysfunction Market revenue (US$ Million) By Cause, (US$ Million) 2019-2031
8.4.2. Latin America Endothelial Dysfunction Market revenue (US$ Million) By Test Type, (US$ Million) 2019-2031
8.4.3. Latin America Endothelial Dysfunction Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.4.4. Latin America Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) By Cause, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) By Test Type, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ZOLL Medical Corp,
9.2.2. Sphingo Tec GmbH,
9.2.3. Lawrence Berkeley National Laboratory,
9.2.4. The Polymath Co,
9.2.5. Endothelix Inc,
9.2.6. Perimed AB,
9.2.7. SMART Medical Ltd,
9.2.8. Everist Health Inc,
9.2.9. Alam Medical SaRl,
9.2.10. Medizinische Messtechnik GmbH
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們